Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | TP53 | P04637 | 3/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | THRB | P10828 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.31 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.31 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12629267 | 0.98 | TSHR (0.70) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL9354091 | 0.83 | TSHR (0.53) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL195103 | 0.81 | — | — | |
| SCHEMBL25514 | 0.81 | TSHR (1.00) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL4602612 | 0.81 | TSHR (1.00) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL8636795 | 0.81 | TSHR (1.00) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL18134826 | 0.81 | TSHR (1.00) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL12701599 | 0.81 | TSHR (1.00) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL56001 | 0.81 | TSHR (1.00) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL10314657 | 0.81 | TSHR (1.00) | TSHRALDH1A1TP53HIF1AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110135749-A1 | LOW SHRINKAGE MULTIFUNCTIONAL SSQ RESINS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-09 | — | — | US | claimed |
| WO-2009110848-A1 | LOW SHRINKAGE MULTIFUNCTIONAL SSQ RESINS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-09-11 | — | — | WO | claimed |
| US-8278077-B2 | Esterification of acrylic acid or ester with such as diethoxylated propargyl alcohol; curable acrylate resins; bright electroplating additive intermediates; mild conditions, stabilizer free, high purity | BASF AKTIENGESELLSCHAFT (DE) | 2012-10-02 | — | — | US | disclosed |
| US-8278077-B2 | Esterification of acrylic acid or ester with such as diethoxylated propargyl alcohol; curable acrylate resins; bright electroplating additive intermediates; mild conditions, stabilizer free, high purity | BASF AKTIENGESELLSCHAFT (DE) | 2012-10-02 | — | — | US | disclosed |
| US-20110135749-A1 | LOW SHRINKAGE MULTIFUNCTIONAL SSQ RESINS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-09 | — | — | US | disclosed |
| WO-2011040881-A1 | UNIMOLECULAR LIGAND-INITIATOR DUAL FUNCTIONAL SYSTEMS (UMLIDFS) AND USE THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-04-07 | — | — | WO | disclosed |
| WO-2009110848-A1 | LOW SHRINKAGE MULTIFUNCTIONAL SSQ RESINS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-09-11 | — | — | WO | disclosed |
| US-20080200631-A1 | Enzymatic Production of (Meth)Acrylic Acid Esters | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-21 | — | — | US | disclosed |
| US-20080200631-A1 | Enzymatic Production of (Meth)Acrylic Acid Esters | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-21 | — | — | US | disclosed |
| US-5214077-A | ORGANOSILICON COMPOUNDS CONTAINING (METH)ACRYLOXY GROUPS, THEIR PREPARATION AND USE | WACKER-CHEMIE GMBH (DE) | 1993-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110135749-A1 | LOW SHRINKAGE MULTIFUNCTIONAL SSQ RESINS | SFPQ, PRDX1, SRSF1 | TSHR 4655/4885ALDH1A1 2659/4885TP53 2857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.